Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

NBY NovaBay Pharmaceuticals Inc New

2,1478

0,0278 (1,31%)

26 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

null

NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more NovaBay Pharmaceuticals Charts.

NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more NovaBay Pharmaceuticals Charts.

News NovaBay Pharmaceuticals Inc New

Form 8-K - Current report
Freitag 14 Juni 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 7 Juni 2024 (3 Wochen vor) • Edgar (US Regulatory)

NovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE American
Freitag 7 Juni 2024 (3 Wochen vor) • Business Wire

Form 8-K - Current report
Freitag 31 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 8-K/A - Current report: [Amend]
Freitag 31 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 31 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 31 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 31 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 31 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 31 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 29 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates
Mittwoch 29 Mai 2024 (4 Wochen vor) • Business Wire

Weitere NovaBay Pharmaceuticals Inc New News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen